Advanced Biotherapy Concepts Inc. Names John M. Bendheim Jr. to Its Board of Directors.Business Editors WOODLAND HILLS, Calif.--(BUSINESS WIRE)--July 10, 2000 Advanced Biotherapy biotherapy /bio·ther·a·py/ (-ther´ah-pe) biological therapy. bi·o·ther·a·py n. Treatment of disease with biologicals, such as vaccines. Concepts Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ADVB ADVB Associação dos Dirigentes de Vendas e Marketing do Brasil ) today announced that John M. Bendheim Jr., chairman of the Board of Governors of the Cedars-Sinai Medical Center Cedars-Sinai Medical Center is a world-renowned hospital located in Los Angeles, California. History Cedars-Sinai is the result of a merger in 1961 between two major Los Angeles hospitals, Cedars of Lebanon and Mount Sinai Home for the Incurables, with Steve Broidy as , Los Angeles, president of Inland Homes Inc., a real estate development company located in Southern California, and member of the Advisory Board at the University of Southern California The U.S. News & World Report ranked USC 27th among all universities in the United States in its 2008 ranking of "America's Best Colleges", also designating it as one of the "most selective universities" for admitting 8,634 of the almost 34,000 who applied for freshman admission School of Business, has been appointed to the company's board of directors. "John's relationships in the medical research community will be very important to the company as we continue to implement our business strategy. As chairman of the Cedars Board of Governors, he has played a key role in harnessing significant financial resources for various genetic research projects," stated Edmond Buccellato, ADVB's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We are delighted to have John's active participation on our board. He is playing an important role in our pursuit of scientific and financial collaborations," added Buccellato. ADVB is developing, and has patented, proprietary treatments for a range of autoimmune diseases, which have now been evaluated in approximately 150 patients. These treatments neutralize certain cytokines that are now confirmed to play a major role in a variety of autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, diabetes and systemic lupus erythematosus Systemic Lupus Erythematosus Definition Systemic lupus erythematosus (also called lupus or SLE) is a disease where a person's immune system attacks and injures the body's own organs and tissues. Almost every system of the body can be affected by SLE. . The company is in the process of evaluating alternatives in preparation for further clinical studies that are required to commercialize its product. Statements made in this news release, other than statements of historical fact, are forward-looking statements and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made, including risks associated with the success of clinical trials, the progress of research and product development programs, the regulatory approval process, competitive products, future capital requirements and the extent and breadth of the company's patent portfolio. See the company's public filings with the Securities and Exchange Commission for information about risks that may affect the company. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion